Lung Disease and FLNA Gene Mutations Study
Part of Heart & circulation, Immune system & allergy, Lungs & breathing clinical trials.
This research study looks at how changes in the FLNA gene affect lung health and disease. If you have an FLNA mutation, researchers want to learn more about your lung condition to improve understanding and future treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed FLNA gene mutation (a change in your genetic code)
- You are able and willing to give written permission to join the study
- You have valid health insurance coverage
- You are not pregnant or breastfeeding
- You are able to follow all study visits and procedures for the full study period
- You are not under legal guardianship or custody
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at specific lung cells (called alveolar cells) to understand how smoking and chronic lung disease may change them. You may be invited if you are having lung surgery and can safely take part.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study looks at cells from the lungs of people who developed lung inflammation after chest radiation for cancer. It aims to understand why some people get this reaction, which may help find better treatments.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
This trial looks at the “molecular landscape,” meaning the specific gene changes driving your lung cancer, for people whose non-small cell lung cancer (NSCLC) has rare mutations. The goal is to better understand what those rare changes mean and how they could guide treatment decisions.
Hear when a new Emphysema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.